Featured

Increased consumption and pervasive budgetary constraints are continuing to drive investment and innovation in the healthcare industry.

Addressing the needs of underserved groups provides an opportunity to boost returns and achieve impact.

Fund closings declined more significantly. Some 554 vehicles were wrapped up in the first three quarters, down 43% year over year.

Appetite for promising debuts remains, despite macro jitters. Here are seven charts telling the story of today’s status quo.

Inside: The LP brain drain – how overworked investors are moving on; LPs and GPs butt heads over fees; Blackstone on the opportunities its Tac Opps team is finding in a dislocated climate; Plus much more…

Enthusiasm for the strategy remains steady, as co-investors flock to well-established names.

No fees, no carry is a compelling reason to co-invest, but gaining access can be tough, and transacting at speed a real challenge.

The evolution of co-investment and its subsequent growth has been accellerated in part by lower fees and the muted fundraising environment.

The rise of continuation funds is blurring the lines between them and what might be considered a co-investment.

Demand for co-investment is soaring as GPs seek to preserve capital and cultivate strong LP relationships in a challenging fundraising environment.